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1. INTRODUCTION 
The mould, Tolypocladium inj’atum has been 
shown to produce the efrapeptins, a family of 
closely related hydrophobic peptide antibiotics, 
which are potent inhibitors of the ATPase activity 
of mitochondria, chloroplasts and bacteria [ 1,2]. It 
has been reported briefly that under conditions of 
limited aeration cultures of T. injlatum produce a 
second antibiotic activity distinct from the efrapep- 
tins [3]. We have given the name elvapeptin to this 
antibiotic. 
In this paper we describe the conditions re- 
quired to produce the elvapeptins together with 
details of their extraction and purification. The 
elvapeptins have been shown to be a family of 
closely related peptides which are potent inhibitors 
of mitochondrial ATPase activity. 
2. MATERIALS AND METHODS 
The fermentation medium used routinely for 
antibiotic production contained glucose, 25 g/l; 
maize starch 10 g/l; proteose peptone 10 g/l; tryp- 
tone, 4 g/l and MgS04 l 7 H20, 0.5 g/l. Innocula 
were prepared by dislodging pieces of mycelium 
from an oatmeal agar slope of T. inflatum (IMI 
202309) adding them to the fermentation medium 
(20 ml) and shaking in an orbital incubator at 150 
rev./min for 5 days at 25°C. For large scale pro- 
duction a 2.5% innoculum was added to fermenta- 
tion medium and shaken for a further 9-12 days 
at 25°C. Typically, 400 ml aliquots of medium 
were incubated in 2 1 conical flasks. 
High performance liquid chromatography was 
carried out with a Hewlett-Packard 1084B liquid 
chromatograph. 
Peptides were acetylated in acetic anhydride/ 
methanol (4: 1, v/v) for 3 h at 70°C. The progress 
of the reaction was followed by thin layer chro- 
matographic analysis of the reaction mixture on 
silica gel plates developed with butan- 1 -al/acetic 
acid/water (3: 1: 1, by vol.). The material was de- 
tected using ninhydrin either directly or after acid 
hydrolysis of the peptide on the TLC plate. 
Amino acid analysis was carried out using an 
LKB 4400 Analyser. Gas chromatography was 
performed using an SP 2100 capillary column in- 
stalled in a Hewlett Packard 5840A GC fitted with 
a flame ionisation detector. The preparation of N- 
heptafluorobutyryl amino acid butyl esters was 
based on the procedure described by Felker and 
Bandurski [4]. 
The soluble ATPase from ox-heart mitochondria 
was prepared by the method of Beechey et al. [5]. 
RESULTS AND DISCUSSION 
3.1. Extraction of elvapeptin 
The growth medium was separated from the 
mycelium by centrifugation. The mycelium was 
then washed twice with distilled water. The growth 
medium and the washings were pooled and ad- 
justed to pH 8.5 with 1 M NaOH. The pooled 
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Fig. 1. Isolation of the elvapeptins from an extract of T. inflatum. Crude antibiotic extract from five 400 ml cultures of T. 
inflatum grown in 2 litre unbaffled flasks as described in the methods section was applied to a column of basic alumina 
(12.5 x 1 cm) packed in chloroform. It was eluted at a flow rate of 2 ml/min with increasing concentrations of meth- 
anol in chloroform. The antibiotic activity of 50 ~1 samples from each 10 ml fraction was determined using the micro- 
biological assay. 
aqueous phase was extracted successively with 
three half-volumes of chloroform. The pooled 
chloroform extracts were then evaporated under 
reduced pressure to yield a crude antibiotic prepa- 
ration. The combined yields of crude elvapeptin 
and efrapeptin produced by T. inji’atum was about 
100 mg/l of culture medium. 
3.2. Purijkation and properties of the elvapeptins 
The crude extract of the growth medium was 
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dissolved in chloroform and applied to a column 0- 1% methanol in chloroform are the efrapeptins. 
of basic alumina. The adsorbed material was elut- Concentrations of methanol in chloroform greater 
ed with a step gradient of increasing concentra- than 25% elute a more polar antibiotic activity, the 
tions of methanol in chloroform, see fig. 1. Frac- elvapeptins. They constitute about 50% of the total 
tions of the eluate were applied to filter paper discs antibiotic activity. Other experiments have shown 
for microbiological assay of antibiotic activity, that if the growth medium is well aerated the pro- 
using Bacillus subtilis as the test organism [7]. portion of the elvapeptins produced decreases sig- 
It can be seen from the results presented in fig.1 nificantly. 
that there are two regions of antibiotic activity Attempts to purify the elvapeptin activity fur- 













Fig.2. Resolution of acetylated elvapeptins by HPLC. A 10 d sample of acetylated elvapeptins dissolved in methanol 
was injected onto a 25 x 0.45 cm column packed with Lichrosorb RP-18 (particle size 5 pm) and eluted with acetoni- 
trile/l’% aqueous phosphoric acid (11:9, v/v) at 70°C. The flow rate was 1.6 ml/min. The eluate was monitored by UV 
detection at 210 nm. The letters indicate the acetylated elvapeptins which have been shown to have biological activity. 
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RP-2, RP-8 and RP-18 columns were unsuccessful. 
Analysis of the elvapeptins by high voltage elec- 
trophoresis on paper was performed at pH 2.0, 3.5 
and 6.5, They could be detected with ninhydrin. 
The elvapeptins were positively charged over this 
pH range. It was found subsequently that it was 
possible to acetylate the material which had been 
eluted from the basic alumina column. The acety- 
lated elvapeptins were resolved into several com- 
ponents by reversed phase HPLC on a Lichrosorb 
RP- 18 column eluted with acetonitrile/ 1% aqueous 
phosphoric acid (11:9, v/v). A typical separation is 
shown in fig.2. It can be seen that the material re- 
solves into at least eight components. Four compo- 
nents of the acetylated crude elvapeptin (C,D,E 
and F) were collected separately. These have been 
shown to inhibit the activity of soluble mitochon- 
drial ATPase. The major component, acetylated 
elvapeptin D, was analysed on Lichrosorb RP-18 
to demonstrate its homogeneity, by this assay it 
was greater than 95% pure. This material was used 
for further analysis. 
The amino acid composition was examined by 
ion exchange and gas chromatographic analysis of 
N-heptafluorobutyryl amino acid butyl esters fol- 
lowing total acid hydrolysis (6 M HCl, 105°C for 
48 h). The amino acids, cu-aminoisobutyric acid, 
isovaline, glycine, leucine, pipecolic acid, alanine 
and /3-alanine were shown to be present in the acid 
hydrolysate. These are the same amino acid resi- 
dues that are found in efrapeptin D [8]. In addi- 
tion, quantitative analysis of this data shows these 
amino acids are to be found in the same propor- 
tions as in efrapeptin D. However, elvapeptin D is 
clearly different from efrapeptin D. The latter pep- 
tide is uncharged at all pH values and it has an M, 
of 1618 [S]. In contrast, the M, of elvapeptin D ap- 
pears to be 1639. Fast atom bombardment mass 
spectral analysis suggests both peptides have the 
same N-terminal sequences and that the major dif- 
ference between these peptides lies in the nature of 
their C-terminal residues, the structures of which 
have yet to be elucidated. 
Efrapeptin D is a potent inhibitor of the soluble 
mitochondrial ATPase activity [3]. Since acetylated 
elvapeptin D contains similar amino acid constitu- 
ents we have investigated its ability to inhibit mito- 
chondrial ATPase activity. It can be seen from 
fig.3 that acetylated elvapeptin D does inhibit the 





Fig.3. Inhibition of soluble mitochondrial ATPase ac- 
tivity by acetylated elvapeptin D. The ability of antibio- 
tic material to inhibit the soluble ATPase from ox-heart 
mitochondria was measured by incubating a methanolic 
solution of the antibiotic with the ATPase at 30°C for 50 
min, to allow equilibrium binding. The ATPase activity 
was measured at a constant ATP concentration using an 
ATP regenerating system 161. 
a potency which is somewhat less than that of 
efrapeptin D. 
The site of action of the acetylated elvapeptin D 
appears to be very similar to that of efrapeptin D. 
(1) If either of the peptides and the ATPase are in- 
cubated together the ATPase activity, as mea- 
sured by the coupled enzyme procedure and 
started by the addition of MgATP, is inhibited 
initially but becomes reactivated. This is fol- 
lowed by a return of inhibition caused by the 
rebinding of the peptides. Preincubation of the 
ATPase with either efrapeptin D or acetylated 
elvapeptin D together with ATP + EDTA pre- 
vents the reactivation of the inhibited enzyme 
on the addition of MgATP [9]. 
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(2) An ATPase preparation that has been totally REFERENCES 
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inhibited by- preincubation with 4-chloro-7- 
nitrobenzofurazan (Nbf-Cl) and further treated 
with efrapeptin D or acetylated elvapeptin D 
can be restored to full activity by the addition 
of dithiothreitol. If Nbf-Cl is not present the 
ATPase activity remains inhibited. 
The elvapeptins are a useful addition to the 
spectrum of inhibitors of mitochondrial ATPase 
activity. The presence of a functional group which 
can be derivatised has enabled us to prepare: (a) 
radiolabelled photoaflinity derivatives which we 
are currently using to study the site of action; (b) 
elvapeptins covalently bound to insoluble sup- 
ports, which are useful tools for the separation of 
ATPase from complex mixtures. 
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